Related Experiment Videos
Activated leukocytes, endothelial cells, and effects of pentoxifylline: observations by VEC-DIC microscopy
M Tomita1, Y Fukuuchi, N Tanahashi
1Department of Neurology, School of Medicine, Keio University, Tokyo, Japan.
Abstract:
Using video-enhanced contrast (VEC)-differential interference contrast (DIC) microscopy, ultrastructural observations were made of the activation of polymorphonuclear leukocytes (PMNLs), the interaction between activated PMNLs and endothelial cells (ECs), and the effects of pentoxifylline (PTX). The ECs were obtained from a commercial source as human umbilical cord vein endothelial cells (HUVECs) or were obtained from pig or rat brains. They were cultured on a coverglass with DMEM for about 1 week. The human PMNLs were obtained from the authors' venous blood. The control appearance of the PMNLs resembled an elastic ball covered with fine villi. The PMNL was activated spontaneously and became flattened on the glass surface within 10 min in the observation chamber. The activation of the PMNLs was estimated arbitrarily from the polymorphous changes in cell shape, agitation of the intracellular granules, and apparent increase in adhesiveness. Preadministered PTX prevented such PMNL activation, and the PMNLs remained round for more than 15 min. PMNL activation was accelerated by chemoattractants (PAF, fMLP, and PMA). In one case, a PMNL that had been activated by PMA tended to recover its round shape with PTX, but finally ended by swelling and bursting. When PMNLs were introduced into the EC-containing chamber, they became entrapped by the ECs and activated, with degranulation followed by release of a smoke-like material. After about 3 h, the EC with an attached PMNL shrank and fell into a state of coagulation necrosis. When PTX was introduced at the time of adhesion of the flattened PMNL, the PMNL appeared to be deactivated, becoming smaller and assuming its previous round shape, and detached from the EC. PTX prevented the spontaneous activation of PMNLs, and of deactivated PMNLs even after their adherence to the endothelium.
Insights
Pentoxifylline (PTX) prevents polymorphonuclear leukocyte (PMNL) activation and their damaging interaction with endothelial cells (ECs). This study observed how PTX inhibits PMNLs from adhering to and harming ECs, offering potential therapeutic insights.
Area of Science:
- Cell Biology
- Immunology
- Pharmacology
Background:
- Polymorphonuclear leukocytes (PMNLs) play a crucial role in inflammatory responses.
- Endothelial cells (ECs) form the inner lining of blood vessels and are involved in regulating immune cell interactions.
- The interaction between PMNLs and ECs can lead to tissue damage during inflammation.
Purpose of the Study:
- To investigate the ultrastructural effects of pentoxifylline (PTX) on polymorphonuclear leukocyte (PMNL) activation and their interaction with endothelial cells (ECs).
- To observe the dynamic processes of PMNL activation, adhesion to ECs, and subsequent cellular damage.
- To evaluate the inhibitory effects of PTX on these inflammatory events.
Main Methods:
- Utilized video-enhanced contrast (VEC)-differential interference contrast (DIC) microscopy for real-time ultrastructural observations.
- Observed human PMNLs and cultured endothelial cells (human umbilical cord vein endothelial cells, pig, or rat brain ECs).
- Assessed PMNL activation based on changes in cell shape, granule movement, and adhesiveness; observed interactions in a controlled chamber setting.
Main Results:
- Spontaneous activation of PMNLs was observed, characterized by shape changes and increased adhesiveness.
- Pentoxifylline (PTX) pre-administration prevented PMNL activation, maintaining their round shape.
- Activated PMNLs adhered to ECs, leading to EC shrinkage and coagulation necrosis; PTX treatment de-activated adhered PMNLs, promoting detachment and preventing EC damage.
Conclusions:
- Pentoxifylline (PTX) effectively inhibits spontaneous and chemoattractant-induced PMNL activation.
- PTX prevents PMNLs from adhering to and causing damage to endothelial cells (ECs).
- These findings highlight PTX's potential as a therapeutic agent to mitigate inflammatory tissue damage mediated by PMNL-EC interactions.